ArticleOncoTargets and therapy2019

Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib.

Shen-Cun Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.